TY - JOUR
T1 - Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival
AU - Bublik, Débora R.
AU - Bursać, Sladana
AU - Sheffer, Michal
AU - Oršolić, Ines
AU - Shalit, Tali
AU - Tarcic, Ohad
AU - Kotler, Eran
AU - Mouhadeb, Odelia
AU - Hoffman, Yonit
AU - Fuchs, Gilad
AU - Levin, Yishai
AU - Volarević, Siniša
AU - Oren, Moshe
PY - 2017/1/24
Y1 - 2017/1/24
N2 - The microRNA miR-504 targets TP53 mRNA encoding the p53 tumor suppressor. miR-504 resides within the fibroblast growth factor 13 (FGF13) gene, which is overexpressed in various cancers. We report that the FGF13 locus, comprising FGF13 and miR-504, is transcriptionally repressed by p53, defining an additional negative feedback loop in the p53 network. Furthermore, we show that FGF13 1A is a nucleolar protein that represses ribosomal RNA transcription and attenuates protein synthesis. Importantly, in cancer cells expressing high levels of FGF13, the depletion of FGF13 elicits increased proteostasis stress, associated with the accumulation of reactive oxygen species and apoptosis. Notably, stepwise neoplastic transformation is accompanied by a gradual increase in FGF13 expression and increased dependence on FGF13 for survival ("nononcogene addiction"). Moreover, FGF13 overexpression enables cells to cope more effectively with the stress elicited by oncogenic Ras protein. We propose that, in cells in which activated oncogenes drive excessive protein synthesis, FGF13 may favor survival by maintaining translation rates at a level compatible with the protein qualitycontrol capacity of the cell. Thus, FGF13may serve as an enabler, allowing cancer cells to evade proteostasis stress triggered by oncogene activation.
AB - The microRNA miR-504 targets TP53 mRNA encoding the p53 tumor suppressor. miR-504 resides within the fibroblast growth factor 13 (FGF13) gene, which is overexpressed in various cancers. We report that the FGF13 locus, comprising FGF13 and miR-504, is transcriptionally repressed by p53, defining an additional negative feedback loop in the p53 network. Furthermore, we show that FGF13 1A is a nucleolar protein that represses ribosomal RNA transcription and attenuates protein synthesis. Importantly, in cancer cells expressing high levels of FGF13, the depletion of FGF13 elicits increased proteostasis stress, associated with the accumulation of reactive oxygen species and apoptosis. Notably, stepwise neoplastic transformation is accompanied by a gradual increase in FGF13 expression and increased dependence on FGF13 for survival ("nononcogene addiction"). Moreover, FGF13 overexpression enables cells to cope more effectively with the stress elicited by oncogenic Ras protein. We propose that, in cells in which activated oncogenes drive excessive protein synthesis, FGF13 may favor survival by maintaining translation rates at a level compatible with the protein qualitycontrol capacity of the cell. Thus, FGF13may serve as an enabler, allowing cancer cells to evade proteostasis stress triggered by oncogene activation.
KW - FGF13
KW - MiR-504
KW - P53
KW - Proteostasis
KW - Ribosomal biogenesis
UR - http://www.scopus.com/inward/record.url?scp=85010924546&partnerID=8YFLogxK
U2 - 10.1073/pnas.1614876114
DO - 10.1073/pnas.1614876114
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 27994142
AN - SCOPUS:85010924546
SN - 0027-8424
VL - 114
SP - E496-E505
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 4
ER -